A phase II pilot study of preoperative gemcitabine and bevacizumab-based chemoradiation for patients with resectable adenocarcinoma of the pancreas.
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 27 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Apr 2010 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 14 Oct 2006 New trial record.